Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: A systematic review

被引:10
|
作者
Njiro, Belinda J. [1 ]
Mutagonda, Ritah F. [1 ]
Chamani, Amisa T. [1 ]
Mwakyandile, Tosi [1 ]
Sabas, Deodatus [1 ]
Bwire, George M. [1 ]
机构
[1] Muhimbili Univ Hlth & Allied Sci, POB 65001, Dar Es Salaam, Tanzania
关键词
Chloroquine; Sub-Saharan Countries; Plasmodium falciparum; Pfcrt; Pfmdr1; ANTIMALARIAL-DRUG RESISTANCE; TRANSPORTER GENE; MARKERS; PFCRT; SUSCEPTIBILITY; LUMEFANTRINE; PREVALENCE; MUTATIONS; GENOTYPES; DISTRICT;
D O I
10.1016/j.jiph.2022.03.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A wide spread of chloroquine resistance prompted its discontinued use for treatment of uncomplicated malaria in several African countries. However, disappearances of chloroquine-resistant parasites have been reported in areas with restricted use of chloroquine. This review reports the current prevalence of chloroquine-resistant Plasmodium falciparum using Pfcrt K76T and Pfmdr1 N86Y genotypes. Methods: A PROSPERO registered systematic review searched evidence from PubMed/MEDLINE, Science Direct and Google Scholar. The search included studies on chloroquine-resistant/ susceptible P. falciparum in humans between January 1st, 2000 and May 15th, 2020. The search was conducted on 15th of May, 2020. Results: Out of 519 searched records, 15 studies qualified for final analysis with 8040 samples genotyped for Pfcrt K76T. Of 8040, 43.6% (837/1572; 95%CI: -0.9 to 88.1%) carried resistant genotypes versus 23.0% (1477/ 6468; 95%CI: 15.7-30.2%) while for 4698 samples analyzed for Pfmdr1 N86Y, 52.4% (592/1090; 95%CI: 42.3-62.5%) had resistant genotypes versus 25.9% (1314/3608; 95%CI: 5.8-46.0%), before and after chloroquine withdrawal, respectively. The median time since chloroquine withdrawal to data collection was 7.0 (interquartile range: 4.5-13.5) years. Low prevalence of resistant genotypes (Pfcrt K76T) was reported in Zambia (0%) in 2013, Malawi (0.1%) in 2009, Tanzania (0.2%) in 2018 and Madagascar (0.3%) in 2007 with significant variations in the included studies. Conclusions: Chloroquine-resistant P. falciparum continues to disappear in countries with withdrawal of chloroquine. Areas with significant susceptible parasites, reintroduction of chloroquine can be considered, preferably in combination with other safe and affordable antimalarials. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. CC_BY_NC_ND_4.0
引用
收藏
页码:550 / 557
页数:8
相关论文
共 50 条
  • [1] The challenge of chloroquine-resistant malaria in sub-Saharan Africa
    Nuwaha, F
    HEALTH POLICY AND PLANNING, 2001, 16 (01) : 1 - 12
  • [2] TREATMENT OF CHLOROQUINE-RESISTANT PLASMODIUM-FALCIPARUM MALARIA
    MARKUS, MB
    SOUTH AFRICAN MEDICAL JOURNAL, 1984, 65 (23): : 913 - 913
  • [3] High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria
    Ursing, Johan
    Rombo, Lars
    Bergqvist, Yngve
    Rodrigues, Amabelia
    Kofoed, Poul-Erik
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (08): : 1315 - 1321
  • [4] Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria
    Djimdé, A
    Doumbo, OK
    Steketee, RW
    Plowe, CV
    LANCET, 2001, 358 (9285): : 890 - 891
  • [5] Molecular markers for chloroquine-resistant Plasmodium falciparum malaria in Thailand and Laos
    Labbé, AC
    Bualombai, P
    Pillai, DR
    Zhong, KYJ
    Vanisaveth, V
    Hongvanthong, B
    Looareesuwan, S
    Kain, KC
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2001, 95 (08): : 781 - 788
  • [6] Suicide after treatment of chloroquine-resistant falciparum malaria with quinine
    Adam, I
    Elbashir, ML
    SAUDI MEDICAL JOURNAL, 2004, 25 (02) : 248 - 249
  • [7] Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis
    Sutherland, Colin J.
    Haustein, Thomas
    Gadalla, Nahla
    Armstrongi, Margaret
    Doherty, Justin F.
    Chiodini, Peter L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) : 1197 - 1199
  • [8] Amodiaquine treatment of uncomplicated malaria in children, in an area of chloroquine-resistant Plasmodium falciparum in north-central Nigeria
    Molta, NB
    Oguche, S
    Paw, SD
    Omalu, ICJ
    Afolabi, BM
    Odujok, JB
    Amajoh, CN
    Adeniji, B
    Wuyep, VP
    Ekanem, OJ
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2003, 97 (07): : 663 - 669
  • [9] Comparative efficacy of chloroquine/chlorpheniramine combination and mefloquine for the treatment of chloroquine-resistant Plasmodium falciparum malaria in Nigerian children
    Sowunmi, A
    Oduola, AMJ
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (06) : 689 - 693
  • [10] THE TREATMENT OF IMPORTED TROPICAL MALARIA CAUSED BY THE CHLOROQUINE-RESISTANT STRAINS PLASMODIUM-FALCIPARUM
    LOBAN, KM
    POLOZOK, ES
    EFIMOV, LS
    KHORIN, AT
    TERAPEVTICHESKII ARKHIV, 1987, 59 (01) : 69 - 72